STATE STREET CORP - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 53 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$202,068
-36.2%
138,4030.0%0.00%
Q2 2023$316,943
+209.3%
138,403
+22.9%
0.00%
Q1 2023$102,469
-46.5%
112,603
-50.0%
0.00%
Q4 2022$191,426
+108.1%
225,206
+100.0%
0.00%
Q3 2022$92,000
-17.1%
112,6030.0%0.00%
Q2 2022$111,000
-40.0%
112,6030.0%0.00%
Q1 2022$185,000
-23.6%
112,603
+12.2%
0.00%
Q4 2021$242,000
-24.6%
100,400
+51.2%
0.00%
Q3 2021$321,000
+306.3%
66,400
+124.3%
0.00%
Q2 2021$79,000
+23.4%
29,600
+39.0%
0.00%
Q3 2019$64,000
-16.9%
21,299
+3.8%
0.00%
Q2 2019$77,000
-91.0%
20,510
-90.3%
0.00%
Q1 2019$854,000
+14.2%
212,317
+4.2%
0.00%
Q4 2018$748,000
-52.4%
203,776
+11.2%
0.00%
Q3 2018$1,572,000
-14.0%
183,224
+10.0%
0.00%
Q2 2018$1,828,000
+64.7%
166,638
+72.7%
0.00%
Q1 2018$1,110,000
+10.6%
96,479
-0.6%
0.00%
Q4 2017$1,004,000
-9.1%
97,017
+39.9%
0.00%
Q3 2017$1,104,000
+46.0%
69,353
+11.0%
0.00%
Q2 2017$756,000
-30.8%
62,475
+18.6%
0.00%
Q1 2017$1,093,000
+49.3%
52,696
+2.8%
0.00%
Q4 2016$732,000
-17.8%
51,259
-5.3%
0.00%
Q3 2016$890,000
+118.7%
54,108
+89.2%
0.00%
Q2 2016$407,00028,5950.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$8,746,0001.82%
Telemetry Investments, L.L.C. 263,975$705,0000.97%
CHI Advisors LLC 719,132$1,920,0000.45%
BVF INC/IL 3,678,626$9,822,0000.37%
EcoR1 Capital, LLC 3,579,377$9,557,0000.36%
Orbimed Advisors 8,053,298$21,502,0000.22%
Stonepine Capital Management, LLC 46,886$125,0000.06%
Ikarian Capital, LLC 100,000$267,0000.02%
ALGERT GLOBAL LLC 19,737$53,0000.02%
Windsor Creek Advisors, LLC 14,786$39,0000.01%
View complete list of CORVUS PHARMACEUTICALS INC shareholders